Canadian Association of Neuroscience Nurses

Home
Canada
Calgary, AB
Canadian Association of Neuroscience Nurses

Founded in 1969

10/26/2026

10/26/2026

Not everything we see online is true. And when misinformation spreads, what we share can have real-world consequences — especially in times of crisis.

During Global Media and Information Literacy Week and always, pause to verify the facts before sharing: ask questions, check your sources and do a little extra research to make sure the information is accurate.

10/26/2026

Factor XI/XIa inhibition: What could it mean for secondary stroke prevention?

As research into Factor XI/XIa inhibition progresses, important questions remain about its potential role in clinical practice. What does the evidence tell us, and which patients might benefit from this emerging therapeutic approach?

In this free, CME-accredited educational activity, offered by Medscape in partnership with ESO, experts Ashkan Shoamanesh, Valeria Caso and Thalia Field examine the scientific rationale, clinical evidence and potential implications for future stroke prevention strategies.

👉 Access the activity: https://ow.ly/gmgZ50ZXXfp

🎓 Earn 1 CME Credit / 1 ABIM MOC Point

Medscape

10/26/2026

10/26/2026

A new era of targeted therapies is emerging in brain tumour research. For the first time, a targeted therapy designed specifically for IDH-mutant gliomas is demonstrating meaningful clinical impact—marking an important milestone in the treatment of brain tumours.

At The Neuro, researchers are building on this progress to understand why some tumours respond to treatment while others develop resistance. By combining advanced molecular techniques with real-time analysis of patients’ tumours, they aim to uncover new ways to make therapies more effective and personalized.

Today on Brain Cancer Awareness Day, we highlight the research bringing new possibilities to patients and families affected by brain cancer.

🔗Read the article: https://www.mcgill.ca/neuro/article/advancing-targeted-therapies-brain-tumours
-

Une nouvelle ère de thérapies ciblées se dessine dans la recherche sur les tumeurs cérébrales. Pour la première fois, un traitement ciblé conçu spécifiquement pour les gliomes porteurs d’une mutation du gène IDH démontre des effets cliniques significatifs, marquant une étape importante dans le traitement des tumeurs cérébrales.

Au Neuro, les chercheurs s’appuient sur ces avancées pour comprendre pourquoi certaines tumeurs répondent au traitement, tandis que d’autres développent une résistance. En combinant des techniques moléculaires de pointe à l’analyse en temps réel des tumeurs des patients, ils cherchent de nouvelles façons de rendre les traitements plus efficaces et personnalisés.

En cette Journée de sensibilisation au cancer du cerveau, le 24 octobre, nous mettons en lumière ces travaux qui ouvrent de nouvelles perspectives pour les personnes touchées par le cancer du cerveau et leurs proches.

🔗 Lisez l’article : https://www.mcgill.ca/neuro/fr/article/soins-aux-patients/faire-progresser-les-therapies-ciblees-et-mieux-comprendre-levolution-des-tumeurs

Brain Tumour Foundation of Canada McGill University Centre universitaire de santé McGill - McGill University Health Centre Brain Cancer Society

10/26/2026

40 years ago today, the Supreme Court of Canada made a groundbreaking ruling that stopped people from forcing adults with intellectual disabilities to be sterilized.

The court matter is known as the “Eve” case.

A mother on Prince Edward Island went to court to get permission to have her 24-year-old daughter, "Eve," sterilized. Eve had an intellectual disability. The mother was worried that Eve might get pregnant and that she would not be able to care for a baby. The Supreme Court of Canada ultimately ruled that the answer was no. That unless a medical operation is necessary to save a person's life or treat a serious illness, no one else—not even a parent or a judge—has the right to take away a person's ability to have children without their consent.

The unanimous ruling proved that people with intellectual disabilities have the exact same right to control their own bodies as everyone else.

It was a massive victory for self advocates and disability rights groups.

We thank Dulcie McCallum for sharing her reflections with us on this case. Dulcie is a prominent human rights lawyer, author, and fierce advocate for the equality and inclusion of people with intellectual disabilities. McCallum served as Ombudsperson for the Province of British Columbia, Special Advisor to Canada's Delegation to the UN Convention on the Rights of Persons with Disabilities and former Information and Privacy Commissioner for Nova Scotia.

Read the blog here: https://buff.ly/4UWUMCw

10/26/2026

Culturally safer care starts with listening to the people and communities receiving it.

In our latest blog, Sonia Isaac-Mann shares how First Nations-led care, patient feedback and shared learning can help make cultural safety an expectation across healthcare.

Read the full story: https://ow.ly/H5ko5100h3k

10/26/2026

Address

PO Box 47143 Calgary Creekside RPO
Calgary, AB
T3P0B9

Website

http://www.cann.ca/

Alerts

Be the first to know and let us send you an email when Canadian Association of Neuroscience Nurses posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.